Nicoletta Luppi, Chairwoman and Managing Director of MSD Italia, graduated in Foreign Modern Languages and Literatures with honours and, later, obtained a Master Degree in Business Administration from the LUISS School of Management of Rome.
In 1993, she joined MSD and, over time, held offices of increasing responsibility until reaching the direction of the Cardiovascular-Metabolic Business Unit of MSD and Schering Plough, as well as two group companies (2003 -2010) and, in 2011, created and was at the head of the Market Access & Commercial Operations Direction, always reporting to the Managing Director.
In September 2012, she became Chairwoman and Managing Director of Sanofi Pasteur MSD and, afterwards, she was appointed as Chairwoman of the Vaccine Group of Farmindustria for the two-year period 2015-2016. Since July 2015, she is Chairwoman and Managing Director of MSD Italia and, since 2016, Chairwoman of the LUISS Business School Alumni Association.
In March 2017, she was chosen by AMREF as testimonial for the Social Campaign against female genital mutilation. In the same year, she was awarded the “Premio Minerva-Donna D’Eccellenza” by FederManager, a prestigious prize to a leadership supporting an environment that may encourage work-life balance and diversity.
Nicoletta Luppi was nominated “Businessperson of the Year 2019” in the Pharma category by Fortune Italia.
In January 2020, she joined the Board of Vaccine Europe and the Advisory Board of Kotler Impact Italy.